G. Joshua Liang
Fortune : 4 M $ au 31/10/2026
Fortune : 4 M $ au 31/10/2026
G.
Joshua Liang is Chief Executive Officer & Director at Sichuan Clover Biopharmaceuticals, Inc since 2020, Chief Executive Officer & Executive Director at Clover Biopharmaceuticals Ltd. since 2020, Chief Executive Officer at Clover Biopharmaceuticals USA, Inc. since 2020, Chief Executive Officer & Executive Director at Clover Biopharmaceuticals AUS Pty Ltd. since 2020, General Manager & Director at Zhejiang Clover Biopharmaceutical, Inc. since 2016, Director at Clover Biopharmaceuticals Hong Kong Ltd. since 2020, General Manager & Executive Director at Clover Biopharmaceutical Beijing Co. Ltd. since 2020, and General Manager & Executive Director at Clover Biopharmaceuticals Shanghai Co. Ltd. since 2021.
Education includes undergraduate degree from the University of Pennsylvania in 2014 and undergraduate studies at The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/10/2026 | 24 020 867 ( 1,85 % ) | 4 M $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur Général | 25/12/2020 |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc BiotechnologyHealth Technology Develops vaccines using trimer-tag technology and commercial manufacturing capabilities to improve global health | Directeur Général | 01/06/2020 |
Zhejiang Clover Biopharmaceutical, Inc. | Directeur Général | 01/08/2016 |
Clover Biopharmaceutical Beijing Co. Ltd. | Directeur Général | 01/08/2020 |
Clover Biopharmaceuticals Shanghai Co. Ltd. | Directeur Général | 01/02/2021 |
Clover Biopharmaceuticals USA, Inc.
Clover Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in research, development and manufacturing of vaccines | Directeur Général | 01/04/2020 |
Clover Biopharmaceuticals Aus Pty Ltd. | Directeur Général | 01/12/2020 |
Clover Biopharmaceuticals Hong Kong Ltd. | Directeur/Membre du Conseil | 01/12/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc BiotechnologyHealth Technology Develops vaccines using trimer-tag technology and commercial manufacturing capabilities to improve global health | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Clover Biopharmaceuticals USA, Inc.
Clover Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in research, development and manufacturing of vaccines | Health Technology |
Zhejiang Clover Biopharmaceutical, Inc. | |
Clover Biopharmaceuticals Aus Pty Ltd. | |
Clover Biopharmaceuticals Hong Kong Ltd. | |
Clover Biopharmaceutical Beijing Co. Ltd. | |
Clover Biopharmaceuticals Shanghai Co. Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national